Apple showcases Oxford Nanopore in M3 launch

Contributed by: ACCESS Newswire

Logo

Tags

Biotechnology

LSE:ONT

Oxford Cannabinoid Technologies Holdings plc

Regulatory

More Like This

Oxford Nanopore Expands Compatible Products Programme and Strengthens Multi-Omics Ecosystem

Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK

Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions

UK to create world-first 'early warning system' for pandemics

From left to right: Dr. Iri Sato Baran, Genesis Healthcare (A.D.A.M Innovations), Vice Chair of the Board Ambassador Julia Longbottom, British Embassy Foreign, Commonwealth and Development Office Michel Mommejat, Genesis Healthcare (A.D.A.M Innovations), CEO and Executive Director Gretchen Weightman, Oxford Nanopore Technologies, Senior Vice President Commercial and General Manager APAC, Dr. Toshiharu Furukawa, LDP, Chair of Medical Information Policy and Genomic Medicine, House of Councillors, Hirokazu Shimoda, Japan Agency for Medical Research and Development, Senior Director

Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan

Oxford Nanopore and WeNou Announce a Partnership to Develop and Commercialise the First Rapid and Portable Food Authenticity Sequencing Test to Detect Food Fraud

Business Wire associated0

IonQ Announces Agreement to Acquire Oxford Ionics, Accelerating Path to Pioneering Breakthroughs in Quantum Computing

Omixon Launches NanoTYPE MONO™ and MONOall™ RUO, a Singleplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore's MinION™ Platform